New competition tests ways to reverse biological aging

A six-month competition involving approximately 500 participants has launched to test methods for reversing biological age. Led by founder Christin Glorioso, the initiative utilizes various assessment tools, including epigenetic blood analysis, brain imaging, facial aging software, and physical strength metrics. While results have already shown extreme variances—with one individual testing 29 years younger than their actual age and another scoring significantly higher—experts note that the current landscape of over 100 different aging metrics lacks universal reliability for personal medical use.

The project aims to compile an extensive global dataset regarding aging clocks to advance longevity science. For the biotechnology sector, this contest provides a cost-effective method to gather information, offering an alternative to traditional, expensive clinical trials. By centralizing diverse biological data, the competition seeks to refine how companies understand and measure the aging process.